© 1996 American Heart Association, Inc.
Articles |
Phospholamban Gene Dosage Effects in the Mammalian Heart
From the Departments of Pharmacology and Cell Biophysics (W.L., I.L.G., J.M.H., K.H., J.P.S., E.G.K.), Physiology and Biophysics (D.G.F., G.G.), and Molecular Genetics, Biochemistry, and Microbiology (T.D.), University of Cincinnati (Ohio), College of Medicine; and the Department of Physiology and Biophysics (B.M.W., R.J.S.), University of Illinois at Chicago, College of Medicine.
Correspondence to Evangelia G. Kranias, PhD, Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, 231 Bethesda Ave, PO Box 670575, Cincinnati, OH 45267-0575.
Abstract Phospholamban ablation has been shown to result in significant increases in cardiac contractile parameters and loss of ß-adrenergic stimulation. To determine whether partial reduction in phospholamban levels is also associated with enhancement of cardiac performance and to further examine the sensitivity of the contractile system to alterations in phospholamban levels, hearts from wild-type, phospholamban-heterozygous, and phospholamban-deficient mice were studied in parallel at the subcellular, cellular, and organ levels. The phospholamban-heterozygous mice expressed reduced cardiac phospholamban mRNA and protein levels (40±5%) compared with wild-type mice. The reduced phospholamban levels were associated with significant decreases in the EC50 of the sarcoplasmic reticulum Ca2+ pump for Ca2+ and increases in the contractile parameters of isolated myocytes and beating hearts. The relative phospholamban levels among wild-type, phospholamban-heterozygous, and phospholamban-deficient mouse hearts correlated well with the (1) EC50 of the Ca2+-ATPase for Ca2+ in sarcoplasmic reticulum, (2) rates of relaxation and contraction in isolated cardiac myocytes, and (3) rates of relaxation and contraction in intact beating hearts. These findings suggest that physiological and pathological changes in the levels of phospholamban will result in parallel changes in sarcoplasmic reticulum function and cardiac contraction.
Key Words: heart • phospholamban • sarcoplasmic reticulum • cardiomyocytes • working heart preparations
This article has been cited by other articles:
 |
|
 |
|
  P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al. Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury Circ. Res., April 24, 2009; 104(8): 1012 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Waggoner, K. S. Ginsburg, B. Mitton, K. Haghighi, J. Robbins, D. M. Bers, and E. G. Kranias Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H698 - H703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sainte-Marie, A. N. D. Cat, R. Perrier, L. Mangin, C. Soukaseum, M. Peuchmaur, F. Tronche, N. Farman, B. Escoubet, J.-P. Benitah, et al. Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block FASEB J, October 1, 2007; 21(12): 3133 - 3141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kaye, A. Preovolos, T. Marshall, M. Byrne, M. Hoshijima, R. Hajjar, J. A. Mariani, S. Pepe, K. R. Chien, and J. M. Power Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals J. Am. Coll. Cardiol., July 17, 2007; 50(3): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mattiazzi, C. Mundina-Weilenmann, C. Guoxiang, L. Vittone, and E. Kranias Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions Cardiovasc Res, December 1, 2005; 68(3): 366 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Janczewski, M. Zahid, B. H Lemster, C. S Frye, G. Gibson, Y. Higuchi, E. G Kranias, A. M Feldman, and C. F McTiernan Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model Cardiovasc Res, June 1, 2004; 62(3): 468 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Minamisawa, Y. Wang, J. Chen, Y. Ishikawa, K. R. Chien, and R. Matsuoka Atrial Chamber-specific Expression of Sarcolipin Is Regulated during Development and Hypertrophic Remodeling J. Biol. Chem., March 7, 2003; 278(11): 9570 - 9575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Schmitt, M. Kamisago, M. Asahi, G. H. Li, F. Ahmad, U. Mende, E. G. Kranias, D. H. MacLennan, J. G. Seidman, and C. E. Seidman Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban Science, February 28, 2003; 299(5611): 1410 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhao, K. F Frank, G. Chu, M. J Gerst, A. G Schmidt, Y. Ji, M. Periasamy, and E. G Kranias Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state Cardiovasc Res, January 1, 2003; 57(1): 71 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ito, X. Yan, M. Tajima, Z. Su, W. H. Barry, and B. H. Lorell Contractile Reserve and Intracellular Calcium Regulation in Mouse Myocytes From Normal and Hypertrophied Failing Hearts Circ. Res., September 29, 2000; 87(7): 588 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Grossman Defining Diastolic Dysfunction Circulation, May 2, 2000; 101(17): 2020 - 2021. [Full Text] [PDF]
|
|
|
|
|
|
A. G. Brittsan, A. N. Carr, A. G. Schmidt, and E. G. Kranias Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban J. Biol. Chem., April 14, 2000; 275(16): 12129 - 12135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, J. Desantiago, G. Chu, E. G. Kranias, and D. M. Bers Phosphorylation of phospholamban and troponin I in beta -adrenergic-induced acceleration of cardiac relaxation Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H769 - H779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Bluhm, E. G. Kranias, W. H. Dillmann, and M. Meyer Phospholamban: a major determinant of the cardiac force-frequency relationship Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H249 - H255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt, R. J. Hajjar, C. S. Kim, D. Lebeche, A. A. Doye, and J. K. Gwathmey Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H474 - H480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sutliff, J. B. Hoying, V. J. Kadambi, E. G. Kranias, and R. J. Paul Phospholamban Is Present in Endothelial Cells and Modulates Endothelium-Dependent Relaxation : Evidence From Phospholamban Gene-Ablated Mice Circ. Res., February 19, 1999; 84(3): 360 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mirit, A. Palmon, Y. Hasin, and M. Horowitz Heat acclimation induces changes in cardiac mechanical performance: the role of thyroid hormone Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R550 - R558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Periasamy, T. D. Reed, L. H. Liu, Y. Ji, E. Loukianov, R. J. Paul, M. L. Nieman, T. Riddle, J. J. Duffy, T. Doetschman, et al. Impaired Cardiac Performance in Heterozygous Mice with a Null Mutation in the Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2 (SERCA2) Gene J. Biol. Chem., January 22, 1999; 274(4): 2556 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A Doevendans, M. J. Daemen, E. D de Muinck, and J. F Smits Cardiovascular phenotyping in mice Cardiovasc Res, July 1, 1998; 39(1): 34 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, G. Chu, E. G. Kranias, and D. M. Bers Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1335 - H1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Luss, P. Bokniek, G. Heusch, F. U. Muller, J. Neumann, W. Schmitz, and R. Schulz Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart Cardiovasc Res, March 1, 1998; 37(3): 606 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Luo, G. Chu, Y. Sato, Z. Zhou, V. J. Kadambi, and E. G. Kranias Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation J. Biol. Chem., February 20, 1998; 273(8): 4734 - 4739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Gao, N. G. Perez, and E. Marban Calcium cycling and contractile activation in intact mouse cardiac muscle J. Physiol., February 15, 1998; 507(1): 175 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Lorenz and E. G. Kranias Regulatory effects of phospholamban on cardiac function in intact mice Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2826 - H2831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chu, G. W. Dorn II, W. Luo, J. M. Harrer, V. J. Kadambi, R. A. Walsh, and E. G. Kranias Monomeric Phospholamban Overexpression in Transgenic Mouse Hearts Circ. Res., October 19, 1997; 81(4): 485 - 492. [Abstract] [Full Text]
|
|
|
|
|
|
C. F. McTiernan, B. H. Lemster, C. Frye, S. Brooks, A. Combes, and A. M. Feldman Interleukin-1ß Inhibits Phospholamban Gene Expression in Cultured Cardiomyocytes Circ. Res., October 19, 1997; 81(4): 493 - 503. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Flesch, F. Schiffer, O. Zolk, Y. Pinto, S. Rosenkranz, C. Hirth-Dietrich, G. Arnold, M. Paul, and M. Bohm Contractile Systolic and Diastolic Dysfunction in Renin-Induced Hypertensive Cardiomyopathy Hypertension, September 1, 1997; 30(3): 383 - 391. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Hajjar, U. Schmidt, J. X. Kang, T. Matsui, and A. Rosenzweig Adenoviral Gene Transfer of Phospholamban in Isolated Rat Cardiomyocytes : Rescue Effects by Concomitant Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase Circ. Res., August 19, 1997; 81(2): 145 - 153. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Slack, I. L. Grupp, D. G. Ferguson, N. Rosenthal, and E. G. Kranias Ectopic Expression of Phospholamban in Fast-Twitch Skeletal Muscle Alters Sarcoplasmic Reticulum Ca2+ Transport and Muscle Relaxation J. Biol. Chem., July 25, 1997; 272(30): 18862 - 18868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Koss and E. G. Kranias Phospholamban: A Prominent Regulator of Myocardial Contractility Circ. Res., December 1, 1996; 79(6): 1059 - 1063. [Full Text]
|
|
|
|
|
|
G. Chu, J. W. Lester, K. B. Young, W. Luo, J. Zhai, and E. G. Kranias A Single Site (Ser16) Phosphorylation in Phospholamban Is Sufficient in Mediating Its Maximal Cardiac Responses to beta -Agonists J. Biol. Chem., December 1, 2000; 275(49): 38938 - 38943. [Abstract] [Full Text] [PDF]
|
|